Oncology drug “value framework” gives doctors, patients a shorthand equation
You can assess the value of common cancer therapies to decide the best and most cost-effective course of treatment for your patients with a new tool from the American Society of Clinical Oncology (ASCO).
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.